Advanced search×

Extracellular superoxide dismutase attenuates release of pulmonary hyaluronan from the extracellular matrix following bleomycin exposure

FEBS Lett 584(13):6 (2010) PMID 20493858 PMCID PMC2892677

The major pulmonary antioxidant enzyme involved in the protection of the lung interstitium from oxidative stress is extracellular superoxide dismutase (EC-SOD). It has been previously shown that EC-SOD knock-out mice are more susceptible to bleomycin-induced lung injury, however, the molecular mechanism(s) remains unclear. We report here that bleomycin-induced lung damage, in EC-SOD KO mice, is associated with increased hyaluronan release into alveolar fluid. Analysis of hyaluronan synthase gene expression and hyaluronan molecular weight distribution suggested that elevated levels of hyaluronan in the alveolar fluid are mostly due to its release from the interstitium. Our results indicate that EC-SOD attenuates bleomycin-induced pulmonary injury, at least in part, by preventing superoxide-mediated release of hyaluronan into alveolar space.

Copyright © 2010 Elsevier Ltd. All rights reserved.

DOI: 10.1016/j.febslet.2010.05.025
Version: za2963e q8za9 q8zbf q8zc8 q8zdd q8zed q8zfc q8zg8

Similar articles you may find interesting…

  1. Analysis of the tolerance of pathogenic enterococci and Staphylococcus aureus to cell wall active antibiotics.

    J Antimicrob Chemother (2013) PMID 23649229

    We demonstrated that the dependence on SOD of tolerance to vancomycin and penicillin is a common trait of antibiotic-susceptible pathogenic enterococci. By varying the levels of expression we could also show that tolerance to vancomycin is directly correlated to SOD activity. Interestingly, deletion...
  2. Association of Mn-SOD Mutation (c.47T > C) with Various POAG Clinical Indices.

    Ophthalmic Genet (2013) PMID 23647424

    This mutation could be associated with various clinical indices important for POAG. If similar findings were found in other populations and larger cohorts, then this SNP may be used as a marker for assessing the severity of the disease....
  3. Localization of putative binding sites for cyclic guanosine monophosphate and the anti-cancer drug 5-fluoro-2[prime]-deoxyuridine-5[prime]-m...

    BMC Struct Biol 13(1):7 (2013) PMID 23641929

    ABCC11 would present two binding sites for cGMP and for 5FdUMP. Substrates likely first bind at the intracellular side of the transmembrane segment while ABCC11 is open forward the cytoplasm (inward-facing conformation). Then, along with conformational changes, it would pass through ABCC11 and fix t...